These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9846808)

  • 1. Effects of a cardioselective M2 receptor antagonist, AF-DX 116, on ventricular arrhythmias in dogs.
    Naito H; Furukawa Y; Hashimoto K
    Heart Vessels; 1997; 12(5):229-33. PubMed ID: 9846808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of anti-M2-muscarinic effect of AF-DX 116 on atrioventricular nodal conduction with those of pirenzepine and atropine as antibradyarrhythmic drugs.
    Sasaki S; Motomura S
    J Cardiovasc Pharmacol; 1999 Jun; 33(6):912-21. PubMed ID: 10367595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide.
    Xue YX; Arita J; Aye NN; Hashimoto K
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):649-56. PubMed ID: 9879724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic effects of combined application of class I antiarrhythmic drugs; addition of low-dose mexiletine-enhanced antiarrhythmic effects of disopyramide and aprindine in various-rate canine ventricular tachycardias.
    Awaji T; Hashimoto K
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):960-6. PubMed ID: 7687723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic effect of a new class 1 antiarrhythmic drug, AN-132, on ventricular arrhythmias in beagles.
    Hashimoto K; Watanabe K; Mitsuhashi H
    Cardiovasc Drugs Ther; 1989 Oct; 3(5):683-9. PubMed ID: 2488108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias.
    Xue Y; Yamada C; Aye NN; Hashimoto K
    Br J Pharmacol; 1998 Aug; 124(8):1712-8. PubMed ID: 9756388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gallopamil, a Ca2+ channel blocker in models of ventricular arrhythmia in dogs.
    Matsuzaki T; Haruno A; Hashimoto K
    Eur J Pharmacol; 1993 Feb; 231(3):363-70. PubMed ID: 8449229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of zatebradine on ouabain-, two-stage coronary ligation- and epinephrine-induced ventricular tachyarrhythmias.
    Furukawa Y; Xue YX; Chiba S; Hashimoto K
    Eur J Pharmacol; 1996 Apr; 300(3):203-10. PubMed ID: 8739209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonist.
    Giachetti A; Micheletti R; Montagna E
    Life Sci; 1986 May; 38(18):1663-72. PubMed ID: 3754611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs.
    Chen J; Xue Y; Eto K; Ni C; Hashimoto K
    J Cardiovasc Pharmacol; 1996 Oct; 28(4):576-84. PubMed ID: 8891885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic effects of MS-551, a new class III antiarrhythmic agent, on canine models of ventricular arrhythmia.
    Kamiya J; Ishii M; Katakami T
    Jpn J Pharmacol; 1992 Feb; 58(2):107-15. PubMed ID: 1507517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic effect of a new class 1 antiarrhythmic drug, nicainoprol, on canine ventricular arrhythmias.
    Hashimoto K; Akiyama K; Mitsuhashi H
    Jpn J Pharmacol; 1989 Feb; 49(2):245-54. PubMed ID: 2733262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AF-DX 116, a cardioselective muscarinic antagonist in humans: pharmacodynamic and pharmacokinetic properties.
    Schulte B; Volz-Zang C; Mutschler E; Horne C; Palm D; Wellstein A; Pitschner HF
    Clin Pharmacol Ther; 1991 Oct; 50(4):372-8. PubMed ID: 1914372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic plasma concentrations of cibenzoline on canine ventricular arrhythmias.
    Hashimoto K; Akiyama K; Mitsuhashi H
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):148-53. PubMed ID: 2435991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165.
    Hashimoto K; Ishii M; Komori S; Mitsuhashi H
    Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New 5-aminoacyl-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-ones with antiarrhythmic activity.
    Poppe H; Kaverina NV; Lyskovzev VV; Egerland U; Sauer W; Lichoscherstow A; Rüger C; Skoldinow A
    Pharmazie; 1997 Nov; 52(11):821-30. PubMed ID: 9399338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic plasma concentrations of pirmenol on canine ventricular arrhythmias.
    Hashimoto K; Watanabe K; Sugiyama A
    Jpn J Pharmacol; 1988 Oct; 48(2):273-82. PubMed ID: 3210450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic effects of HOE642, a novel Na(+)-H+ exchange inhibitor, on ventricular arrhythmias in animal hearts.
    Xue YX; Aye NN; Hashimoto K
    Eur J Pharmacol; 1996 Dec; 317(2-3):309-16. PubMed ID: 8997615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of selected antiarrhythmic drugs on coronary artery ligation-induced ventricular arrhythmias on the right or left sides.
    Gautam CS; Sharma PL; Pandhi P
    Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):327-31. PubMed ID: 8830201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dual model for cardiac arrhythmias: coexistence of re-entry and abnormal automaticity and effects of antiarrhythmic agents.
    Wu KM; Hunter T; Proakis A
    Br J Pharmacol; 1989 Sep; 98(1):268-74. PubMed ID: 2508981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.